BOMBAY BURMAH TRADING CORPORATION
Back to Income Statement
|
BOMBAY BURMAH TRADING CORPORATION Last 5 Year Revenue History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹17,109 Cr | ₹16,623 Cr | ₹14,507 Cr | ₹13,396 Cr | ₹11,889 Cr |
What is the latest Revenue of BOMBAY BURMAH TRADING CORPORATION ?
Year | Revenue |
---|---|
Mar2024 | ₹17,109 Cr |
Mar2023 | ₹16,623 Cr |
Mar2022 | ₹14,507 Cr |
Mar2021 | ₹13,396 Cr |
Mar2020 | ₹11,889 Cr |
How is Revenue of BOMBAY BURMAH TRADING CORPORATION Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹17,109 Cr | 2.92 | |
Mar2023 | ₹16,623 Cr | 14.58 | |
Mar2022 | ₹14,507 Cr | 8.29 | |
Mar2021 | ₹13,396 Cr | 12.67 | |
Mar2020 | ₹11,889 Cr | - |
Compare Revenue of peers of BOMBAY BURMAH TRADING CORPORATION
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BOMBAY BURMAH TRADING CORPORATION | ₹12,816.0 Cr | -2.9% | -15.1% | 10.6% | Stock Analytics | |
KAVERI SEED COMPANY | ₹5,042.1 Cr | 0.9% | 8.7% | 49.4% | Stock Analytics | |
VENKYS (INDIA) | ₹2,332.8 Cr | -0.7% | -1.6% | -9.1% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,511.4 Cr | 2% | 1.3% | -40.7% | Stock Analytics | |
MANGALAM GLOBAL ENTERPRISE | ₹470.4 Cr | 18.4% | 6.2% | NA | Stock Analytics | |
INDO US BIOTECH | ₹437.8 Cr | -0.7% | -3.4% | -13.3% | Stock Analytics |
BOMBAY BURMAH TRADING CORPORATION Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BOMBAY BURMAH TRADING CORPORATION | -2.9% |
-15.1% |
10.6% |
SENSEX | -0.8% |
-1.6% |
3.1% |
You may also like the below Video Courses